< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 61
- Overcoming resistance to anti-PD1 blockade in uterine leiomyosarcomasFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Post-mortem tissue biobanking to illuminate end-stage ovarian cancer disease (ATLASOvCANCER)From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advisory Board Cancer Infertility Pregnancy (ABCIP)From1 Jan 2023 → 31 Dec 2023Funding: Other federal public and semi-governmental institutions
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Impact of prenatal exposure to cancer treatment during pregnancy and of chemotherapy for breast cancer on the brains: a multimodal MR imaging studyFrom1 Dec 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
421 - 430 of 584
- Breast Cancer Susceptibility Polymorphisms and Endometrial Cancer Risk: a Collaborative Endometrial Cancer Study(2011)
Authors: Diether Lambrechts, Ignace Vergote, Frédéric Amant
Pages: 1862 - 1866 - Psycho-oncology: structure and profiles of European centers treating patients with gynecological cancer(2011)
Authors: Frédéric Amant
Pages: 1520 - 1524 - A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy(2011)
Authors: Frédéric Amant, Ignace Vergote
Pages: 1347 - 1353 - Training in bowel and upper abdominal surgery in gynaecological oncology: European Society of Gynecological Oncology (ESGO) Statement(2011)
Authors: Frédéric Amant
Pages: 1264 - 5 - Cognitive and Cardiac Outcome After Prenatal Exposure to Chemotherapy in Children 18 Months or Older(2011)
Authors: Frédéric Amant, Kristel Van Calsteren, M Mhallem Gziri, Lieven Lagae, M Willemsen, L Kapusta, Ben Van Calster, L Mertens, PB Ottevanger
Pages: 8 - 8 - Chemotherapy during pregnancy(2011)
Authors: Liesbeth Heyns, Kristel Van Calsteren, Sileny Han, Mina Mhallem Gziri, Patrick Augustijns, Frédéric Amant
Pages: 101 - 106 - Polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma(2011)
Authors: Sandrina Lambrechts, Kristel Van Calsteren, Steven Joniau, Dirk Timmerman, Frédéric Amant
Pages: 475 - 478 - Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients(2011)
Authors: Frédéric Amant, Patrick Neven, Ignace Vergote
Pages: 191 - 198 - Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer(2011)
Authors: Ignace Vergote, Frédéric Amant
Pages: S88 - S92 - Management Aimed at Fertility Preservation(2011)
Authors: Frédéric Amant
Pages: S68 - S68